Treatment and outcome among the 106 AK patients
No (%) | |
---|---|
Antiamoebal medical therapy: | |
Propamidine/hexamidine | 86 (81) |
PHMB | 72 (68) |
Chlorhexidine | 40 (38) |
Neomycin | 25 (24) |
Oral/topical antifungal | 7 (7) |
Duration of medical therapy | |
(excluding 39 patients still on medication/lost to follow up) | |
Mean: | 5.2 months |
Median: | 4.3 months |
Range: | 25–503 months |
Surgery (14 patients) | |
Penetrating keratoplasty | 9 |
Superficial keratectomy | 6 |
Cataract extraction | 5 |
Amniotic membrane transplant | 2 |
Trabeculectomy/cyclodiode | 2 |
Lid surgery | 2 |
Lamellar keratoplasty (41 patients still under review) | 1 |
Final visual acuity: | |
Discharged patients (54 eyes) | |
6/6 or better | 37 (68) |
6/9 | 14 (26) |
6/12 | 3 (6) |
Patients under review or lost to follow up (60 eyes) | |
6/6 or better | 19 (32) |
6/9 | 12 (20) |
6/12 | 7 (12) |
6/18–6/60 | 9 (15) |
1/60–3/60 | 2 (3) |
Hand movements/perception of light | 9 (15) |
No recent acuity available | 2 (3) |